Universal Health Services (UHS) cash flow statement

Health Care Facilities · NYSE · Health Care

$191.98 -2.94% Close Nov 17, 2026 Live

TrendArc score 68 of 100 · Health 7.6 · Momentum 6.7 · Moat 7.9 · scored Nov 17, 2026 · How the score works

Free cash flow, fiscal year to December 31, 2025

$825 million

down 26.6% from the year before

Universal Health Services generated $825 million of free cash flow in the fiscal year to December 2025: $1.9 billion of cash from operations less $1.0 billion of capital spending. That was 4.7% of revenue, against 7.1% the year before. Over the last four quarters, to September 30, 2026, it was $1.1 billion.

What stands out

  • Over the five fiscal years to December 2025 it paid $4.5 billion in dividends and net share repurchases, 161% of its free cash flow over the same years.
  • Diluted shares outstanding fell 24.7% over the five fiscal years to December 2025.
  • Free cash flow was below net income in each of the last five fiscal years; in the fiscal year to December 2025 it was 55% of net income.
  • It paid cash dividends in each of the last ten fiscal years.

Each sentence is written by a fixed rule from the figures on this page.

Free cash flow and net income, the last 10 fiscal years

$500M$1.00B$1.50B$2.00B2016201720182019202020212022202320242025$814MFree cash flow $825MNet income $1.49B$500M$1.00B$1.50B$2.00B20172019202120232025Free cash flow $825MNet income $1.49B

Fiscal years, each labelled by the calendar year it ended in. Every figure is in the statement below.

Where the cash wentFiscal year to December 31, 2025

  1. Cash from operations 1.86
  2. Capital spending -1.04
  3. Free cash flow 0.82
  4. Businesses bought and sold, net -0.03
  5. Net share repurchases -0.95
  6. Dividends -0.05
  7. Debt and other 0.26
  8. Net change in cash 0.05

In billions of US dollars. Outflows are grey, not red: a buyback is not a loss. "Debt and other" closes the gap to the reported change in cash. Buying marketable securities moves cash into short-term investments; the balance sheet shows both.

Cash flow statement, the last 10 fiscal years

In billions of US dollars. Each column is a fiscal year, named by the month it ended; the first column adds up the last four quarters. Cash paid out is a negative number.
Fiscal year toLast 4 quarters
to Sep 2026
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating activities
Net income1.491.140.720.680.990.940.810.780.750.70
Depreciation and amortisation0.620.580.570.580.530.510.490.450.450.42
Stock-based pay0.100.100.100.090.090.070.070.070.070.060.09
Working capital and other items-0.340.24-0.11-0.35-0.710.840.06-0.02-0.010.12
Cash from operations2.061.862.071.271.000.882.361.441.271.251.33
Investing activities
Capital spending-0.96-1.04-0.94-0.74-0.73-0.86-0.73-0.63-0.66-0.56-0.52
Businesses bought and sold, net-0.030.020.02-0.01-0.06-0.05-0.03-0.15-0.06-0.64
Investments bought and sold, net0.000.01-0.040.090.00-0.02-0.020.07-0.060.00
Cash from investing-1.07-0.91-0.76-0.65-0.91-0.80-0.69-0.75-0.68-1.16
Financing activities
Debt issued or repaid, net0.24-0.430.100.620.22-0.16-0.02-0.04-0.100.71
Shares issued less bought back-1.06-0.95-0.66-0.53-0.82-1.21-0.19-0.76-0.39-0.35-0.34
Dividends paid-0.05-0.05-0.05-0.06-0.06-0.07-0.02-0.05-0.04-0.04-0.04
Other financing0.01-0.010.00-0.06-0.01-0.01-0.01-0.03-0.02-0.50
Cash from financing-0.75-1.14-0.49-0.32-1.07-0.38-0.85-0.49-0.52-0.17
Net change in cash0.050.010.010.02-1.101.17-0.090.030.050.00
Free cash flow
Free cash flow1.090.821.120.520.260.031.630.800.610.690.81
Free cash flow margin6.0%4.7%7.1%3.7%2.0%0.2%14.1%7.1%5.7%6.6%8.3%
Free cash flow per share$12.79$16.54$7.48$3.55$0.33$19.03$9.03$6.50$7.16$8.27

Shares issued less bought back is the cash from shares sold less the cash paid for shares bought back (negative when more was bought back), and includes tax withheld when employees' shares vest. Working capital and other items is cash from operations less net income, depreciation and amortisation, and stock-based pay (calculated by TrendArc). Company filings as standardised by Tiingo; calculations by TrendArc. Rebuilt nightly.

Universal Health Services against its peers

CompanyFiscal year toFree cash flowFree cash flow margin
Veeva SystemsVEEV Jan 2026$1.39B43.4%
Quest DiagnosticsDGX Dec 2025$1.36B12.3%
DaVitaDVA Dec 2025$1.31B9.6%
LabcorpLH Dec 2025$1.21B8.6%
Universal Health ServicesUHS Dec 2025$825M4.7%
Henry ScheinHSIC Dec 2025$521M4.0%
Hims & Hers HealthHIMS Dec 2025$57.4M2.4%
CenteneCNC Dec 2025$4.32B2.2%
SolventumSOLV Dec 2025-$10.0M-0.1%
Peer median6.3%

Each company's newest fiscal year; some end in other months. The peers are the stock card's peer group.

Next

Follow Universal Health Services with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes Universal Health Services from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.